Scarica l'app Stockscreener
265.06
1.16%
2.895
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUM Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$262.17
Aprire:
$262.17
Volume 24 ore:
507.65K
Relative Volume:
0.26
Capitalizzazione di mercato:
$31.91B
Reddito:
$123.11B
Utile/perdita netta:
$1.58B
Rapporto P/E:
20.34
EPS:
13.0294
Flusso di cassa netto:
$2.44B
1 W Prestazione:
-8.74%
1M Prestazione:
-2.61%
6M Prestazione:
-7.14%
1 anno Prestazione:
+3.77%
Intervallo 1D:
$261.20
$266.20
Intervallo di 1 settimana:
$256.69
$285.99
Portata 52W:
$206.87
$315.35
Humana Inc Stock (HUM) Company Profile
Nome
Humana Inc
Settore
Industria
Telefono
(502) 580-1000
Indirizzo
500 W MAIN ST, LOUISVILLE, KY
Confronta HUM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
265.30 | 31.46B | 123.11B | 1.58B | 2.44B | 13.03 |
|
UNH
Unitedhealth Group Inc
|
357.99 | 325.98B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
81.35 | 101.03B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
ELV
Elevance Health Inc
|
349.35 | 78.92B | 189.25B | 5.35B | 5.34B | 23.49 |
|
CI
Cigna Group
|
292.50 | 80.65B | 261.22B | 5.40B | 3.94B | 18.31 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-22 | Iniziato | Evercore ISI | In-line |
| 2025-05-01 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-10-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-10-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-06-24 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-03-22 | Iniziato | Raymond James | Mkt Perform |
| 2024-03-13 | Downgrade | Argus | Buy → Hold |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-01-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Aggiornamento | Argus | Hold → Buy |
| 2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Downgrade | Argus | Buy → Hold |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-10-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Iniziato | Bernstein | Mkt Perform |
| 2022-04-13 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-11-04 | Reiterato | Barclays | Overweight |
| 2021-11-04 | Reiterato | Credit Suisse | Outperform |
| 2021-11-04 | Reiterato | Morgan Stanley | Overweight |
| 2021-11-04 | Reiterato | Oppenheimer | Outperform |
| 2021-11-04 | Reiterato | RBC Capital Mkts | Outperform |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-09-09 | Ripresa | Barclays | Overweight |
| 2021-07-09 | Iniziato | Seaport Global Securities | Neutral |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-01-04 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Iniziato | Bernstein | Mkt Perform |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-16 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-06-05 | Iniziato | Goldman | Buy |
| 2020-01-03 | Reiterato | JP Morgan | Overweight |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-09-30 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Iniziato | UBS | Neutral |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-12-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Reiterato | BofA/Merrill | Buy |
| 2018-09-13 | Iniziato | Barclays | Overweight |
| 2018-07-12 | Ripresa | Morgan Stanley | Overweight |
| 2018-07-06 | Reiterato | Piper Jaffray | Overweight |
| 2018-06-01 | Ripresa | Citigroup | Buy |
| 2018-02-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Reiterato | Leerink Partners | Outperform |
| 2018-01-12 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Humana Inc Borsa (HUM) Ultime notizie
Why Humana Inc. stock is a must watch in 2025Weekly Investment Report & Free Reliable Trade Execution Plans - newser.com
Is Humana Inc. stock oversold or undervaluedQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Is Humana Inc. stock poised for growth2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Humana loses second lawsuit challenging Medicare Advantage star ratings - Healthcare Finance News
Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides - ts2.tech
Can Humana Inc. stock deliver strong Q4 earnings2025 Buyback Activity & AI Enhanced Trading Alerts - newser.com
What makes Humana Inc. stock attractive to growth fundsQuarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - newser.com
What MACD signals say about Humana Inc.Portfolio Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
Behind Humana’s plan to fix its Medicare Advantage star ratings - Modern Healthcare
Humana Medicare Advantage Crisis: Ratings Meltdown Puts Senior Healthcare at Risk - International Business Times UK
Humana Inc. $HUM Shares Purchased by Vanguard Personalized Indexing Management LLC - MarketBeat
Will Humana Inc. stock deliver shareholder value2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Can Humana Inc. stock sustain market leadership2025 Volatility Report & Weekly Hot Stock Watchlists - newser.com
Humana Stock Slumps After Reportedly Losing Lawsuit Seeking To Undo Cuts To Medicare Bonus Payments - Stocktwits
How institutional ownership impacts Humana Inc. stock2025 Market Trends & Long Hold Capital Preservation Plans - newser.com
Louisville Humana awards $12 million in grants to help seniors' well-being - WDRB
Humana's 2025 Medicare Ratings Sound, Judge Says - Law360
Insurer's shares plummet as it stands to lose billions - Insurance Business America
Major Health Insurer Dealt Legal Blow Over Medicare Advantage Ratings - Newsweek
Montrose Regional Heath to end contract with Humana Medicare Advantage - WesternSlopeNow.com
Humana Loses Court Battle Over Medicare Advantage Ratings, Billions In Payments At Risk - Benzinga
The Sports Brief: Humana’s pickleball play, EA Sports and The Athletic team up and more - Campaign US
Humana loses Medicare Advantage stars lawsuit for a second time - Healthcare Dive
Humana loses Medicare Advantage star ratings lawsuit - Modern Healthcare
Humana loses challenge to 2025 Medicare Advantage ratings - MSN
Humana Loses Second Lawsuit to Reverse Medicare Bonus Cuts - Bloomberg.com
Why Humana (HUM) Shares Are Sliding Today - Yahoo Finance
Humana loses 2nd legal challenge to MA star ratings - Fierce Healthcare
Humana loses challenge to 2025 Medicare Advantage ratings By Reuters - Investing.com
Humana slips after losing lawsuit to reverse Medicare Star ratings - TradingView
Humana Foundation targets better senior emotional health with expanded grant effort - Lane Report
Humana rebuffed by federal court in challenge over Medicare plan Star Ratings ( - Seeking Alpha
Humana stock falls after losing Medicare bonus lawsuit, Goldman sell rating - Investing.com
Humana hosting pickleball pop-up at Woodfield Mall Saturday - Daily Herald
Humana Foundation Expands National Efforts to Improve Seniors’ Emotional Health – Company Announcement - Financial Times
Humana price exposed to negative pressureForecast today14-10-2025 - Economies.com
Humana (HUM) Stock Signal 14/10: Is More Downside Ahead? - DailyForex
How Humana Inc. stock reacts to weak economyWeekly Investment Summary & Stock Timing and Entry Methods - newser.com
Hospital dropping Humana Medicare Advantage; offers patient resources - Montrose Daily Press
Concerns rise over Mercy Health / Humana negotiations - WKBN.com
Agent groups urge feds to stabilize MA as another carrier cuts commissions - InsuranceNewsNet
Jim Cramer: Humana (HUM) Keeps Rising – A “Totally Independent” Healthcare Stock - MSN
How Humana Inc. stock performs in stagflationMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Humana Inc. stock outlook for YEAR2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - newser.com
Women CFOs Outperform. Here’s How Humana And Merck Prove It. - Forbes
Using economic indicators to assess Humana Inc. potentialJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Humana : Invitation to presentation of Humana's report on third quarter 2025 - MarketScreener
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
How to escape a deep drawdown in Humana Inc.Trade Entry Summary & Precise Buy Zone Identification - newser.com
Humana Inc Azioni (HUM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
1.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):